Neurogen Corporation Company Profile
Based in Branford, CT., Neurogen Corporation is a drug development company historically focusing on small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders with significant unmet medical need. Neurogen has conducted its drug development independently and, when advantageous, collaborated with world-class pharmaceutical companies to access additional resources and expertise.
News Articles
A.P. Pharma Appoints Barry Quart and Stephen Davis to Its Board of Directors
A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today announced the appointment of Barry D. Quart, Pharm.D., and Stephen R. Davis, to its board of director...
A.P. Pharma Appoints Thomas Pitler, Ph.D. as Vice President of Business Development
A.P. Pharma, Inc. (OTCBB: APPA) today announced the appointment of Thomas Pitler, Ph.D. as vice president of business development. “Tom has extensive business de...
Drugs and Medications
None
PubMed Articles
Adult hippocampal neurogenesis: An actor in the antidepressant-like action.
Depression and anxiety are psychiatric illnesses that are major burdens in society and affect as much as 7% of the world's population. The heterogeneous nature of depression suggests an involvement of...
Diagnosis of mitochondrial disorders applying massive pyrosequencing.
Mitochondrial disorders are a frequent cause of neurological disability affecting children and adults. Traditionally, molecular diagnosis of mitochondrial diseases was mostly accomplished by the use o...
The design, synthesis, and structure-activity relationships of a novel series of pyrazines, acting as corticotropin releasing factor-1 (CRF-1) receptor antagonists, are described. Synthetic methodolog...
Procedural learning refers to the acquisition of motor skills and the practice that refines their performance. The striatum participates in this learning through a function regulated by endocannabinoi...
Clinical Trials
None
Companies
Based in Branford, CT., Neurogen Corporation is a drug development company historically focusing on small-molecule drugs to improve the lives of patients suffering from psychiatri...
Neurogen is a small molecule drug discovery and development company targeting new drug candidates to improve the lives of patients suffering from pain, insomnia, inflammation, depression, and obesity....
Neurogen Corporation & Ligand Pharmaceuticals
Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory di...
More Information about "Neurogen Corporation" on BioPortfolio
We have published hundreds of Neurogen Corporation news stories on BioPortfolio along with dozens of Neurogen Corporation Clinical Trials and PubMed Articles about Neurogen Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neurogen Corporation Companies in our database. You can also find out about relevant Neurogen Corporation Drugs and Medications on this site too.
